Bexson Biomedical
PrivateLast Round
Series A
Feb 2, 2021
Est. Valuation
$17M
Total Funding Raised
$10.3M
Company Overview
Bexson Biomedical is a biopharmaceutical company that develops therapies and delivery solutions for pain management, addiction, and mental health disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bexson Biomedical Comparables
Compare Bexson Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmaTher Holdings Ltd. | 83% | |
| Silo Pharma, Inc. | 76% | |
| Mycrodose Therapeutics | 74% |
Bexson Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 2, 2021 |
Bexson Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noetic Fund | Series A |
| The Conscious Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 799% MoM, reaching 1.9K.
- Feb 2, 2021
$5M round led by Noetic Fund
Bexson Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bexson Biomedical's valuation, stock price, and market status.
Is Bexson Biomedical a public or private company?
Bexson Biomedical is a private company.
What is the current stock price of Bexson Biomedical?
Bexson Biomedical is a private company, so its shares have no public market price. Caplight tracks Bexson Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bexson Biomedical worth (valuation)?
Bexson Biomedical's valuation is estimated at $17.0M based on funding round data.
Can I buy Bexson Biomedical stock?
Bexson Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bexson Biomedical's last funding round?
Bexson Biomedical's most recent funding round was Series A on February 2, 2021.
Who are the main investors in Bexson Biomedical?
Key investors in Bexson Biomedical include Noetic Fund.
Will Bexson Biomedical IPO soon?
No public IPO plans have been announced for Bexson Biomedical.
How can I track Bexson Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in Bexson Biomedical's shares on secondary markets.